The development of a predictive biomarker for immunotherapy outcome based on flow cytometry test

Project Information

BioFlow

Grant agreement ID: 101081690

DOI

10.3030/101081690

Project closed

EC signature date 1 August 2022

Start date 1 September 2022

End date 29 February 2024

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (1)

Data Management Plan

Publications

Peer reviewed articles (1)

Interferon-stimulated neutrophils as a predictor of immunotherapy response

Author(s): Madeleine Benguigui 1, Tim J Cooper 2, Prajakta Kalkar 3, Sagie Schif-Zuck 3, Ruth Halaban 4, Antonella Bacchiocchi 4, Iris Kamer 5, Abhilash Deo 1, Bar Manobla 1, Rotem Menachem 1, Jozafina Haj-Shomaly 1, Avital Vorontsova 1, Ziv Raviv 1, Chen Buxbaum 1,
Published in: Cancer Cell, 2024, ISSN 1535-6108
Publisher: Cell Press
DOI: 10.1016/j.ccell.2023.12.005